United StatesFexofenadine Hydrochloride Tablets, USP 180 mg, 150 tablets per bottle (NDC 66336-561-30), distributed by Ohm Laboratories, Inc., are being recalled by Sun Pharmaceutical Industries Inc. Affected lots: Lot DNG0283A (exp 03/31/2027) and Lots DNF0922A and DNF0923B (exp 10/31/2026). The recall is for failure to meet impurities/degradation specifications; 9,048 bottles were distributed nationwide in the United States.
What's being recalled
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
The hazard
Failed Impurities/Degradation Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)